spacer
home > ict > winter 2017 > out of control
PUBLICATIONS
International Clinical Trials

Out of Control

The first documented outbreak of the Ebola virus disease – more commonly known as Ebola – occurred in 1976 in South Sudan and the Democratic Republic of the Congo. Nearly 40 years later in 2013, the most widespread outbreak of Ebola in history started in the West African country of Guinea and quickly spread to the neighbouring countries of Liberia and Sierra Leone.

While previous outbreaks were brought under control within a matter of weeks, this one became an epidemic that raged on for over two years, resulting in more than 11,000 deaths and significant social disruption. A number of factors contributed to the failure to control this flare-up, including extreme poverty in the affected areas; a dysfunctional healthcare system in affected countries; a population with enormous distrust of government officials after years of armed conflict; several months of delay in government agency response to the outbreak; and the unprecedented spread of Ebola to densely populated cities.

Even with previous Ebola epidemics on record, there were no licensed vaccines, no treatments with proven efficacy in humans and no diagnostics that met the WHO’s target product profile for a rapid, simple Ebola virus disease test at the start of this spread. The lack of effective treatments, combined with the severity of the breakout, triggered an unprecedented global response to tackle the epidemic that provides a compelling case study for accelerated drug development models.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
goBalto’s Chief Executive Officer Sujay Jadhav has over 20 years of experience with leading Silicon Valley software providers with a life sciences focus. Most recently, he was Senior Vice President of Global Corporate Strategy and Development at Model N, and held a variety of roles in Strategy Consulting at Booz Allen Hamilton, Product Strategy at CommerceOne and General Management at Singapore Telecom. Sujay received his Bachelor’s degree from the University of South Australia and an MBA from Harvard University, US.
spacer
Sujay Jadhav
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

PCI Pharma Services Announces Further Expansion in San Diego to Maintain Industry-Leading Quality, Service and Flexibility

Philadelphia, PA – June 4, 2019 PCI Pharma Services (PCI), a leading biopharmaceutical outsourcing services provider, has announced the growth of its West Coast Clinical operations with expansion into its third facility in San Diego.
More info >>

White Papers

Key to Outsourcing Method Development and Validation: A Pragmatic Approach

RSSL

In an industry that is seeing an increasing level of work being outsourced, the Contract Research Organisation (CRO) of choice needs to have proven experience in both the pragmatism and flexibility of the method developer’s mind set and a regulatory background in validation. As companies are focussing on achieving ever shorter times of drug to market, it is vital that a tailored, pragmatic approach is adopted when engaging in both method development and validation activities for an Active Pharmaceutical Ingredient (API) or drug product (DP). Although methods still require a high degree of robustness, the overall strategy should encompass a full evaluation of the regulatory requirements applicable to the particular phase of the drug life-cycle; this is pivotal in Key to Outsourcing Method Development and Validation A Pragmatic Approach order to ensure a successful regulatory submission, where the applicant must demonstrate suitable validation of all methods used to support the filing.
More info >>

 
Industry Events

SCOPE Europe – Summit for Clinical Ops Executives Europe

17-18 September 2019, Barcelona, Spain

Building on the success of its long-running US-based counterpart, Summit for Clinical Trials Operations Executives Europe (SCOPE Europe) is a two-day event serving clinical innovation leaders, clin ops execs, functional heads, category managers, and those responsible for the planning and management of clinical trials in Europe and the Rest of the World. The event will feature opening and closing plenary keynote sessions, five conference tracks, interactive breakout discussion groups, and networking. It is an opportunity for leaders from large, mid-sized, and small pharma, specialty pharma, biotech, vendor companies, and academic research centers to come together to share best practices and discuss the new era of analytics-driven and patient-centric trials.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement